Short Term Reduction in the Odds of Testing Positive for SARS-CoV-2; a Comparison Between Two Doses and Three doses of the BNT162b2 Vaccine
bioRxiv (2021) - Comments
doi: 10.1101/2021.08.29.21262792 

Tal Patalon, Sivan Gazit, Virginia E. Pitzer, Ottavia Prunas, Joshua L. Warren, Daniel M. Weinberger